American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

L Harris, H Fritsche, R Mennel, L Norton… - Journal of clinical …, 2007 - ascopubs.org
Purpose To update the recommendations for the use of tumor marker tests in the prevention,
screening, treatment, and surveillance of breast cancer. Methods For the 2007 update, an …

Human body fluid proteome analysis

S Hu, JA Loo, DT Wong - Proteomics, 2006 - Wiley Online Library
The focus of this article is to review the recent advances in proteome analysis of human
body fluids, including plasma/serum, urine, cerebrospinal fluid, saliva, bronchoalveolar …

Plasma membrane proteomics and its application in clinical cancer biomarker discovery

R Leth-Larsen, RR Lund, HJ Ditzel - Molecular & Cellular Proteomics, 2010 - ASBMB
Plasma membrane proteins that are exposed on the cell surface have important biological
functions, such as signaling into and out of the cells, ion transport, and cell-cell and cell …

Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry

JYMN Engwegen, MCW Gast, JHM Schellens… - Trends in …, 2006 - cell.com
Recently, the focus of cancer research has expanded from genetic information in the human
genome to protein expression analyses. Because this 'proteome'reflects the state of a cell …

Proteomic approaches for serum biomarker discovery in cancer

P Maurya, P Meleady, P Dowling… - Anticancer research, 2007 - ar.iiarjournals.org
Monitoring the protein expression pattern in tumour cells by proteomics technologies offers
opportunities to discover potentially new biomarkers for the early detection and diagnosis of …

High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein–bound mass signatures

MF Lopez, A Mikulskis, S Kuzdzal, DA Bennett… - Clinical …, 2005 - academic.oup.com
Background: Researchers typically search for disease markers using a “targeted” approach
in which a hypothesis about the disease mechanism is tested and experimental results …

[HTML][HTML] A machine learning perspective on the development of clinical decision support systems utilizing mass spectra of blood samples

H Shin, MK Markey - Journal of Biomedical Informatics, 2006 - Elsevier
Currently, the best way to reduce the mortality of cancer is to detect and treat it in the earliest
stages. Technological advances in genomics and proteomics have opened a new realm of …

The consumption of seaweed as a protective factor in the etiology of breast cancer: proof of principle

J Teas, S Vena, DL Cone, M Irhimeh - Journal of applied phycology, 2013 - Springer
Daily consumption of seaweed has been proposed as a factor in explaining lower
postmenopausal breast cancer (BC) incidence and mortality rates in Japan. This clinical trial …

Cancer proteomics

HT Tan, YH Lee, MCM Chung - Mass spectrometry reviews, 2012 - Wiley Online Library
Cancer presents high mortality and morbidity globally, largely due to its complex and
heterogenous nature, and lack of biomarkers for early diagnosis. A proteomics study of …

[HTML][HTML] On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer

J Penkert, T Ripperger, M Schieck, B Schlegelberger… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Altered metabolism in tumor cells has been a focus of cancer research for as long as a
century but has remained controversial and vague due to an inhomogeneous overall …